Antithrombotic Efficacy and Bleeding Risks of Vaccine-Induced Immune Thrombotic Thrombocytopenia Treatments
H. Leung, Z. Ahmadi, J. Casey, S. Ratnasingam, S. McKenzie, J. Perdomo, B. Chong
This study evaluates anticoagulants and IVIg for treating VITT, finding danaparoid reduces IgG-PF4 binding and FcγRIIa blockade is most effective for thrombosis and thrombocytopenia.
bioRxiv · Apr 21, 2024Immunology